Fuad El-Hibri
2021
Compensation breakdown
| Option Awards | $1,020,779 |
|---|---|
| Salary | $1,190,867 |
| Stock Awards | $1,300,072 |
| Other | $4,259 |
| Total | $3,515,977 |
El-Hibri received $1.3M in stock awards, accounting for 37% of the total pay in 2021.
El-Hibri also received $1M in option awards, $1.2M in salary and $4.3K in other compensation.
Rankings
In 2021, Fuad El-Hibri's compensation ranked 3,804th out of 12,415 executives tracked by ExecPay. In other words, El-Hibri earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,804 out of 12,415 | 69th |
Division Manufacturing | 1,557 out of 5,505 | 72nd |
Major group Chemicals And Allied Products | 632 out of 2,375 | 73rd |
Industry group Drugs | 561 out of 2,096 | 73rd |
Industry Pharmaceutical Preparations | 391 out of 1,546 | 75th |
Pay ratio
| Fuad El-Hibri's Pay | $3,515,977 |
|---|---|
| Median Employee's Pay | $110,416 |
| Pay Ratio | 32to 1 |
In 2021, the annual total compensation of Fuad El-Hibri was $3,515,977.
The annual total compensation of the median employee at Emergent BioSolutions was $110,416.
The ratio of Fuad El-Hibri's pay to the pay of median employee was therefore 32 to one.
El-Hibri's colleagues
We found four more compensation records of executives who worked with Fuad El-Hibri at Emergent BioSolutions in 2021.
2021
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2021
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
2021
Adam Havey
Emergent BioSolutions
Chief Operating Officer
2021
Atul Saran
Emergent BioSolutions